How Companies in Argentina Can Source Pharma Products & CDMO Services (2026 Guide)
Argentina • Source Pharma Products & CDMO Services
Introduction
Argentina has a long-established pharmaceutical industry, and a large share of the medicines sold locally are made by domestic laboratories. Imports still matter: local formulators buy APIs and excipients abroad, hospitals and health insurers need specialty and sterile products, and brand owners use contract manufacturers (CDMOs) to add products without new plant investment.
This guide explains where Argentine buyers typically source, how to qualify a foreign supplier for ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica), what documents customs and the regulator expect, and how to handle the practical issues that slow imports. For market context, see our Argentine pharmaceutical market overview and the Argentina country hub.
Where supply comes from
Argentine buyers usually combine several regions, choosing each source according to product complexity, price and the regulatory record of the site.
| Supply base | What buyers typically source | What to check |
|---|---|---|
| China and India | Generic APIs, intermediates, excipients and many finished generics | GMP status accepted by ANMAT, impurity profiles, stability data |
| Europe (EU-GMP) | Complex generics, sterile injectables, hormones, specialty and orphan products | EU-GMP certificate, Spanish packaging capability |
| United States | Specialty, biologic and high-value hospital products | FDA inspection history, COPP availability |
| Brazil, Mexico and other Latin American sources | Finished products for regional portfolios, contract packaging, biosimilars | Mercosur origin rules, Spanish artwork already in place |
| South Korea and Japan | Biosimilars and specialty injectables | Cold chain for long transits |
Because a product's registration is often linked to a site in a country listed by ANMAT as a high-surveillance country, the origin of the finished product can shape the registration route as much as the price. Plan the two together.
Pharma categories supply
- APIs and excipients: the largest category by volume, bought by local laboratories for analgesics, antibiotics, cardiovascular and diabetes products.
- Oncology and high-cost medicines: injectables and targeted therapies purchased by hospitals, health insurers (obras sociales and prepagas) and public programmes.
- Sterile injectables and hospital products: antibiotics, anaesthetics and critical-care vials, often supplied through institutional tenders.
- Biologics and biosimilars: imported finished or as bulk for local fill and finish.
- OTC products and supplements: vitamins and food supplements, which follow different rules from medicines.
- CDMO and contract packaging: outsourced manufacture or packaging for local brand owners and regional exporters.
How to source pharma products
- Define the product and route. Confirm the molecule, strength, dosage form and pack. Decide whether you need a new registration, a product already registered by a local holder, or supply for a tender or exceptional access.
- Confirm the local holder. ANMAT registrations are held by an Argentine company authorised by ANMAT as an importer or laboratory, with a pharmacist as technical director. A foreign manufacturer works through that holder.
- Shortlist qualified sites. Ask for current GMP certificates (WHO-GMP, EU-GMP, US FDA or a PIC/S authority). Check whether the site is in an ANMAT high-surveillance country or has been inspected by ANMAT, because this affects the documents and the timeline.
- Review the technical file. Request a CTD-structured dossier, CoAs for recent batches, stability data for the right conditions, bioequivalence data where ANMAT requires it, and the API documentation.
- Agree commercial terms. Settle MOQ, lead time, Incoterms, Spanish artwork, payment terms and currency.
- Test before scaling. Order samples or a pilot batch and have it tested locally before placing volume orders.
PharmaTradz works with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa. You can send a single, structured requirement through our request for quotation page and receive responses from sites that match your product and route. For help with the file itself, see our dossier licensing and registration support.
Required documents for import
Imports of medicines into Argentina go through ANMAT control and through the customs service, now part of ARCA (the federal revenue and customs agency that replaced AFIP). Prepare these documents before shipment.
Regulatory documents
- ANMAT registration certificate for the product, or the authorisation for exceptional access
- ANMAT authorisation of the importing company
- Certificate of Pharmaceutical Product (COPP) or free sale certificate from the country of origin, where required
- GMP certificate of the manufacturing site, legalised or apostilled where needed
- Certificate of Analysis for each batch
- ANMAT import intervention or release for each consignment
Commercial and shipping documents
- Commercial invoice and packing list with batch numbers and expiry dates
- Bill of lading or air waybill
- Certificate of origin, for Mercosur or other preferences
- Temperature logs for cold-chain goods
- Safety data sheet for APIs
Foreign documents normally need a Spanish translation by a sworn translator. Confirm the apostille and translation requirements with your holder before the supplier issues anything.
Logistics and shipping
Main entry points
- Sea: the Port of Buenos Aires handles most container imports, with river ports on the Paraná, such as Rosario and Zárate, serving the interior.
- Air: Ministro Pistarini International Airport at Ezeiza (EZE) is the main air cargo gateway for pharmaceuticals, with temperature-controlled storage.
Indicative transit times
| Origin | Sea freight to Buenos Aires | Air freight to Ezeiza |
|---|---|---|
| South and East Asia | Typically 35 to 50 days | Typically 3 to 7 days |
| Europe | Typically 20 to 30 days | Typically 1 to 3 days |
| Brazil and other Mercosur partners | Road or short-sea, typically under 10 days | Typically 1 to 2 days |
Allow extra time for customs and ANMAT release, especially for first shipments.
Cold chain, Incoterms and customs
Vaccines, biologics and many injectables need 2 to 8°C control throughout. Use GDP-qualified forwarders, validated packaging and data loggers, and book cold storage at Ezeiza in advance. Our cold-chain pharma logistics page covers the main checks. FCA or CIP terms are common for air freight and FOB or CIF for sea. Work with a customs broker (despachante de aduana) who handles ANMAT-controlled goods, and check current import and foreign-exchange rules before you agree payment terms.
Legal and regulatory overview
- Regulator: ANMAT, under the Ministry of Health. Argentina is a member of PIC/S.
- Legal basis: Law 16.463 on medicines, with registration rules set by Decree 150/1992 and ANMAT dispositions.
- Registration holder: an Argentine company authorised by ANMAT, with a technical director.
- Registration routes: Decree 150/1992 lists high-surveillance countries. Products already authorised and marketed in one of them can follow a shorter route than products from other origins, which need fuller evidence and proof of GMP accepted by ANMAT.
- GMP: ANMAT may inspect foreign plants, or accept certificates from authorities of high-surveillance countries.
- Stability: WHO lists long-term conditions of 25°C/60% RH (Zone II) for Argentina. If you also supply Brazil, ask for 30°C/75% RH data too.
- Labelling: labels and the package insert must be in Spanish and follow ANMAT rules. Some medicines are also subject to the national traceability system.
- Timelines: registration typically takes several months to more than a year, depending on the route and the completeness of the file.
Routes without a full registration
ANMAT runs an exceptional access regime (RAEM) for unregistered medicines needed by individual patients, and controls imports for clinical trials. Public hospitals, provinces and national programmes buy through tenders, which generally require a product registered with ANMAT.
Common challenges and practical solutions
| Challenge | Practical solution |
|---|---|
| Registration route unclear | Map the origin country and the reference market before choosing a supplier. A site in a high-surveillance country can shorten the path. |
| GMP evidence not accepted | Check early whether ANMAT will need its own inspection, and budget for it. |
| Changing import and currency rules | Review current rules with your broker and bank before each contract, and keep payment terms flexible. |
| Spanish labels and package inserts | Agree artwork ownership in the contract, and have the holder's technical director approve final proofs. |
| Long lead times | Plan production and shipping three to four months ahead for sea freight, and keep safety stock of critical items. |
| Quality variation between batches | Test pilot batches locally and include CoA and stability commitments in the quality agreement. |
Conclusion
Sourcing for Argentina works best when the regulatory route is settled first. Confirm the local holder, check whether the site's origin qualifies for the shorter route, confirm the GMP evidence ANMAT will accept, and then compare prices across regions. Asian sources are strong on generic APIs and volume products, while European and US sites remain common for complex sterile and biologic products.
PharmaTradz connects Argentine laboratories, importers and distributors with qualified manufacturers in every major supply region, so you can compare options on quality as well as price.
Frequently Asked Questions
Who regulates medicine imports in Argentina?
ANMAT regulates the registration, import and marketing of medicines. Customs clearance is handled by the customs service within ARCA, with ANMAT release for controlled products.
Can a foreign manufacturer register a medicine directly with ANMAT?
No. The registration is held by an Argentine company authorised by ANMAT, with a technical director. Foreign manufacturers supply through that holder.
What are high-surveillance countries in Argentine registration?
They are countries listed in Decree 150/1992 whose authorisations ANMAT treats as a reference. Products already approved and marketed there can use a shorter registration route.
Which stability conditions apply to Argentina?
WHO lists 25°C/60% RH (Zone II) as the long-term condition. Buyers supplying Brazil as well often request Zone IVb data.
Must labels be in Spanish?
Yes. Labels and package inserts must be in Spanish and follow ANMAT requirements.
Can unregistered medicines be imported for patients?
Yes, in limited cases. ANMAT's exceptional access regime allows imports of unregistered medicines for individual patients, subject to a medical justification and ANMAT approval.
More on Argentina
Source Pharma Products & CDMO Services — other markets
Planning to register or source in Argentina?
Tell us the molecule, dosage form and target market. We will come back on the regulatory pathway and whether the project is realistic before you commit anything.
Submit a Requirement Ask a questionIf you already hold WHO-GMP, EU-GMP, USFDA or PIC/S approval, you are closer to supplying Argentina than you probably think.
Argentina's regulator publishes a register of authorised products. Look up any supplier's claims yourself — including ours.
